{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:39:20Z","timestamp":1787974760508,"version":"build-2784847793"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jaci.2020.04.056","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T21:33:47Z","timestamp":1589837627000},"page":"403-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients\u00a0with HLA-A\u221732:01\u2013positive vancomycin-induced DRESS sharing an HLA class II haplotype"],"prefix":"10.1016","volume":"147","author":[{"given":"Nontaya","family":"Nakkam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie","family":"Mouhtouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Konvinse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha E.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra Y.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Ostrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.04.056_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.04.056_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.056_bib3","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s40265-015-0505-8","article-title":"Lipoglycopeptide antibacterial agents in gram-positive infections: a comparative review","volume":"75","author":"Van Bambeke","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2020.04.056_bib4","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3346\/jkms.2006.21.6.1108","article-title":"A case of hypersensitivity syndrome to both vancomycin and teicoplanin","volume":"21","author":"Kwon","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaci.2020.04.056_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijantimicag.2006.11.022","article-title":"Teicoplanin hypersensitivity syndrome","volume":"29","author":"Lye","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jaci.2020.04.056_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2710.2009.01124.x","article-title":"Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review","volume":"35","author":"Hsiao","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jaci.2020.04.056_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.12659\/AJCR.899149","article-title":"DRESS syndrome caused by cross-reactivity between vancomycin and subsequent teicoplanin administration: a case report","volume":"17","author":"Miyazu","year":"2016","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jaci.2020.04.056_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.medmal.2018.01.002","article-title":"Teicoplanin-induced DRESS syndrome: the importance of skin tests","volume":"48","author":"Ben Romdhane","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.jaci.2020.04.056_bib9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","article-title":"The combined utility of ex\u00a0vivo IFN-gamma release enzyme-linked ImmunoSpot assay and in\u00a0vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions","volume":"6","author":"Trubiano","year":"2018","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920306874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920306874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:30:12Z","timestamp":1758792612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920306874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0091674920306874"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.04.056","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients\u00a0with HLA-A\u221732:01\u2013positive vancomycin-induced DRESS sharing an HLA class II haplotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.04.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}